ReP USP - Resultado da busca

Filtros : "Universidade Estadual de Campinas (UNICAMP)" "2012" "Antunes, E." Limpar

Filtros

Artigo de periodico
BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes (2012)
Soeiro-Pereira, Paulo Vítor; Falcai, Angela; Kubo, Christina Arslanian; Oliveira-Júnior, Edgar Borges; Marques, Otávio Cabral; Antunes, E.; Condino-Neto, Antônio
Source: British Journal of Pharmacology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOEIRO-PEREIRA, Paulo Vítor et al. BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. British Journal of Pharmacology, v. 166, n. 05, p. 1617-1630, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2011.01764.x. Acesso em: 17 out. 2024.
APA
Soeiro-Pereira, P. V., Falcai, A., Kubo, C. A., Oliveira-Júnior, E. B., Marques, O. C., Antunes, E., & Condino-Neto, A. (2012). BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. British Journal of Pharmacology, 166( 05), 1617-1630. doi:10.1111/j.1476-5381.2011.01764.x
NLM
Soeiro-Pereira PV, Falcai A, Kubo CA, Oliveira-Júnior EB, Marques OC, Antunes E, Condino-Neto A. BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes [Internet]. British Journal of Pharmacology. 2012 ; 166( 05): 1617-1630.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/j.1476-5381.2011.01764.x
Vancouver
Soeiro-Pereira PV, Falcai A, Kubo CA, Oliveira-Júnior EB, Marques OC, Antunes E, Condino-Neto A. BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes [Internet]. British Journal of Pharmacology. 2012 ; 166( 05): 1617-1630.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/j.1476-5381.2011.01764.x
Artigo de periodico
Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice (2012)
Silva, F. H. da; Pereira, M. N.; Franco-Penteado, C. F.; De Nucci, Gilberto ; Antunes, E.; Claudino, M. A.
Source: International Journal of Impotence Research. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, F. H. da et al. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, v. 25, n. 2, p. 69-73, 2012Tradução . . Disponível em: https://doi.org/10.1038/ijir.2012.35. Acesso em: 17 out. 2024.
APA
Silva, F. H. da, Pereira, M. N., Franco-Penteado, C. F., De Nucci, G., Antunes, E., & Claudino, M. A. (2012). Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice. International Journal of Impotence Research, 25( 2), 69-73. doi:10.1038/ijir.2012.35
NLM
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 out. 17 ] Available from: https://doi.org/10.1038/ijir.2012.35
Vancouver
Silva FH da, Pereira MN, Franco-Penteado CF, De Nucci G, Antunes E, Claudino MA. Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide - cyclic GMP pathway in mice [Internet]. International Journal of Impotence Research. 2012 ; 25( 2): 69-73.[citado 2024 out. 17 ] Available from: https://doi.org/10.1038/ijir.2012.35

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024